{
    "organizations": [],
    "uuid": "af0ccf9f196ca432df5f716eaa466fdeb6138e4d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-evotec-says-endometriosis-programm/brief-evotec-says-endometriosis-programme-with-bayer-moves-to-phase-i-development-idUSFWN1RV038",
    "ord_in_thread": 0,
    "title": "BRIEF-Evotec Says Endometriosis Programme With Bayer Moves To Phase I Development",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - Evotec AG:\n* DGAP-NEWS: EVOTEC AND BAYER ADVANCE THIRD ENDOMETRIOSIS PROGRAMME INTO PHASE I CLINICAL DEVELOPMENT Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-18T13:34:00.000+03:00",
    "crawled": "2018-04-19T15:02:15.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "evotec",
        "ag",
        "evotec",
        "bayer",
        "advance",
        "third",
        "endometriosis",
        "programme",
        "phase",
        "clinical",
        "development",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}